Song Ailin, Dang Jie, He Zhiyun, Zhang Youcheng, Liu Xiaokang, Zhao Lei, Lv Xi, Li Yumin
VIP Surgical Department of Lanzhou University Second Hospital, Lanzhou.
Center of Children's Medical Examination, Lanzhou University Second Hospital.
Medicine (Baltimore). 2019 Mar;98(10):e14689. doi: 10.1097/MD.0000000000014689.
An increasing number of women undergo breast augmentation at their reproductive age. The most existing evidence focuses on the impact of breast implant on the index women's health and breastfeeding after they give birth to a child. No previous systematic review has investigated the association between breast implant in mother and health outcomes in offspring. In this study, we aimed to conduct a systematic review and meta-analysis to evaluate the influence of breast implant on offspring's health outcomes.
A comprehensive search strategy will be conducted including the following databases: MEDLINE (via PubMed), Embase, Cochrane Central Register of Controlled Trials, Chinese Biomedical Literature Database, China National Knowledge Infrastructure, Wan Fang Data. The World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) will be searched as well for retrieving the ongoing studies. The cohort study and case-control study will be considered as eligible study if investigating the impact of breast implant in mother on health outcomes in offspring. The risk of bias of included studies will be appraised by the Newcastle-Ottawa scale.
The results of this study will be presented in the full-text of the systematic review.
This systematic review and meta-analysis will infer a conclusion on the association between breast implant in mother and health outcomes in offspring, and the quality of existing evidence.PROSPERO registration number: CRD42019121221.
越来越多的育龄女性接受隆胸手术。目前大多数证据集中在乳房植入物对接受手术女性自身健康以及产后母乳喂养的影响上。此前尚无系统评价研究母亲的乳房植入物与后代健康结局之间的关联。在本研究中,我们旨在进行一项系统评价和荟萃分析,以评估乳房植入物对后代健康结局的影响。
将实施全面的检索策略,包括以下数据库:MEDLINE(通过PubMed)、Embase、Cochrane对照试验中心注册库、中国生物医学文献数据库、中国知网、万方数据。还将检索世界卫生组织(WHO)国际临床试验注册平台(ICTRP)以获取正在进行中的研究。如果研究母亲的乳房植入物对后代健康结局的影响,队列研究和病例对照研究将被视为合格研究。纳入研究的偏倚风险将采用纽卡斯尔-渥太华量表进行评估。
本研究结果将在系统评价全文中呈现。
本系统评价和荟萃分析将得出关于母亲的乳房植入物与后代健康结局之间关联以及现有证据质量的结论。
PROSPERO注册号:CRD42019121221。